New hope for myeloma patients too old for transplant?
Disease control
Recruiting now
This study tests a combination of four drugs—iberdomide, bortezomib, dexamethasone, and isatuximab—for people newly diagnosed with multiple myeloma who are not eligible for a stem cell transplant. The goal is to see if this treatment can shrink or eliminate the cancer. About 75 p…
Phase: PHASE2 • Sponsor: Canadian Myeloma Research Group • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC